EFFECTIVENESS AND SAFETY OF MONOCLONAL ANTIBODIES AGAINST PROPROTEIN CONVERTASE SUBTILISIN/KEXIN 9 (PCSK9 INHIBITORS) FOR THE TREATMENT OF HYPERCHOLESTEROLAEMIA
4CPS-032
STUDY OF THE CHARACTERISTICS OF PATIENTS TREATED WITH TOLVAPTAN
4CPS-029
ADHERENCE TO MEDICATION AND SALT RESTRICTION AND BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS
4CPS-024
HUMAN NORMAL IMMUNOGLOBULIN REQUIREMENTS IN PAEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY, FOCUSING ON THE ADMINISTRATION ROUTE SWITCHING
4CPS-023
IMPACT OF DRUG AND THERAPEUTIC COMMITTEE INTERVENTION ON RATIONALISATION OF ALBUMIN USE IN CANCER PATIENTS ADMITTED TO SURGERY WARDS OF A TERTIARY CARE TEACHING HOSPITAL
4CPS-017
MISUSE OF NOVEL ORAL ANTICOAGULANTS IN HOSPITAL SETTINGS
4CPS-014
FOLLOW-UP TO RECOMMENDATIONS ABOUT RENAL FUNCTION MONITORING IN ELDERLY PATIENTS TREATED WITH SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS
4CPS-010
ANALYSIS OF USE OF PROTON PUMP INHIBITORS IN PATIENTS BEFORE HOSPITAL ADMISSION AND AT HOSPITAL DISCHARGE
4CPS-007
INTERDISCIPLINARY TEAM IN THE FOLLOW-UP OF A PATIENT WITH TEDUGLUTIDA
4CPS-257
THE EFFECTIVENESS OF DIFFERENT ORAL CARE SOLUTIONS IN THE TREATMENT OF CHEMOTHERAPYINDUCED ORAL COMPLICATIONS
4CPS-137
HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS
4CPS-131
DIFFERENCES IN UK HEALTHCARE PROFESSIONALS’ KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS INFLIXIMAB AND INSULIN GLARGINE BIOSIMILARS
4CPS-179
ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER IN ADULTHOOD: CONFLICT BETWEEN CLINICAL NEEDS AND PRESCRIPTION STATUS
4CPS-246
IMPACT OF MEDICATION REVIEW TO OPTIMISE PRESCRIPTIONS OF NURSING HOME RESIDENTS
4CPS-241
METABOLIC COMPLICATIONS ASSOCIATED WITH PARENTERAL NUTRITION OF INTENSIVE CARE PATIENTS
